We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Myelin Defects in Niemann–Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives.
- Authors
Bernardo, Antonietta; De Nuccio, Chiara; Visentin, Sergio; Martire, Alberto; Minghetti, Luisa; Popoli, Patrizia; Ferrante, Antonella
- Abstract
Niemann–Pick type C (NPC) disease is a wide-spectrum clinical condition classified as a neurovisceral disorder affecting mainly the liver and the brain. It is caused by mutations in one of two genes, NPC1 and NPC2, coding for proteins located in the lysosomes. NPC proteins are deputed to transport cholesterol within lysosomes or between late endosome/lysosome systems and other cellular compartments, such as the endoplasmic reticulum and plasma membrane. The first trait of NPC is the accumulation of unesterified cholesterol and other lipids, like sphingosine and glycosphingolipids, in the late endosomal and lysosomal compartments, which causes the blockade of autophagic flux and the impairment of mitochondrial functions. In the brain, the main consequences of NPC are cerebellar neurodegeneration, neuroinflammation, and myelin defects. This review will focus on myelin defects and the pivotal importance of cholesterol for myelination and will offer an overview of the molecular targets and the pharmacological strategies so far proposed, or an object of clinical trials for NPC. Finally, it will summarize recent data on a new and promising pharmacological perspective involving A2A adenosine receptor stimulation in genetic and pharmacological NPC dysmyelination models.
- Subjects
MYELIN; CELL membranes; DRUG target; ENDOPLASMIC reticulum; NEUROINFLAMMATION; NEUROMYELITIS optica
- Publication
International Journal of Molecular Sciences, 2021, Vol 22, Issue 16, p8858
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms22168858